Page last updated: 2024-08-25

pancratistatin and piplartine

pancratistatin has been researched along with piplartine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Curran, C; Gilbert, T; Gupta, M; Hudlicky, T; Ma, D; Ma, S; Mansour, F; Noel, M; Pandey, S; Pignanelli, C; Ropat, J; Tarade, D; Vshyvenko, S	1

Other Studies

1 other study(ies) available for pancratistatin and piplartine

Article	Year
Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:1 Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dioxolanes; Drug Synergism; HCT116 Cells; HT29 Cells; Humans; Isoquinolines; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Oxidative Stress; U937 Cells	2018

Article

Year

Exploiting mitochondrial and oxidative vulnerabilities with a synthetic analog of pancratistatin in combination with piperlongumine for cancer therapy.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2018, Volume: 32, Issue:1

Topics: Amaryllidaceae Alkaloids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Dioxolanes; Drug Synergism; HCT116 Cells; HT29 Cells; Humans; Isoquinolines; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms; Oxidative Stress; U937 Cells

2018